High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- 31 March 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (3), 247-256
- https://doi.org/10.1016/s1470-2045(08)70069-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival UpdateJournal of Clinical Oncology, 2006
- Results of Induction Chemotherapy in Children Older Than 1 Year With a Stage 4 Neuroblastoma Treated With the NB 97 French Society of Pediatric Oncology (SFOP) ProtocolJournal of Clinical Oncology, 2005
- Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk NeuroblastomaJournal of Clinical Oncology, 2004
- Best practice in assessing ototoxicity in children with cancerEuropean Journal of Cancer, 2004
- High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG‐1) by the European Neuroblastoma Study GroupPediatric Blood & Cancer, 2004
- Disseminated Neuroblastoma in Children Older Than One Year at Diagnosis: Comparable Results With Three Consecutive High-Dose Protocols Adopted by the Italian Co-Operative Group for NeuroblastomaJournal of Clinical Oncology, 2003
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidThe New England Journal of Medicine, 1999
- Cyclophosphamide/doxorubicin vs. Cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A pediatric oncology group randomized phase II studyMedical and Pediatric Oncology, 1995
- High-dose rapid schedule chemotherapy for disseminated neuroblastomaEuropean Journal of Cancer, 1992
- Ototoxicity of high‐dose cis‐platinum in childrenMedical and Pediatric Oncology, 1988